John M. Fluke Jr - May 30, 2025 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role: Director
Signature: /s/ Mark Worthington, Attorney in fact for John M. Fluke, Jr.
Stock symbol: ATHA
Transactions as of: May 30, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/3/2025, 05:37 PM
Previous filing: May 24, 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
FLUKE JOHN M JR	Director	C/O ATHIRA PHARMA, INC., 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL	/s/ Mark Worthington, Attorney in fact for John M. Fluke, Jr.	2025-06-03	0001191906

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATHA	Stock Option (Right to Buy)	Award	$0	+20.9K		$0.00	20.9K	May 30, 2025	Common Stock	20.9K	$0.31	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option will vest on the earlier of (i) May 30, 2026, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 30, 2025. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.